Hypofractionated Chemoradiotherapy With Tislelizumab and Surufatinib for Unresectable Stage III NSCLC

Abroad (travel likely)RecruitingPHASE2

Conditions

NSCLC (Non-small Cell Lung Cancer)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Sun yat-sen University Cancer Center, Guangzhou, Guangdong, China
Contact: Study coordinator (Hui Liu, Doctor) · liuhuisysucc@126.com · +862087343031

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue

Invasive Ductal Breast Carcinoma · Invasive Ductal Breast Carcinoma Stage IV · Lobular Breast Carcinoma

Abroad (travel likely)Recruiting

Basking Ridge, United States · Middletown, United States

Efficacy and Safety of Super-hyperfractionation Pulse Radiotherapy Combined With ICIs for Advanced NSCLC

Lung Cancer · Immune Checkpoint Inhibitor · Radiotherapy

Abroad (travel likely)Recruiting

Chongqing, China · Chongqing, China

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

Diffuse Astrocytoma, IDH-Mutant · Glioblastoma, IDH-wildtype · Brain Metastases, Adult

Abroad (travel likely)RecruitingPHASE1, PHASE2

Beverly Hills, United States · Glendale, United States

Postoperative Radiotherapy for Postoperative N2 Metastases of NSCLC in the Immunotherapy Era (Phase II)

Non-Small Cell Lung Cancer

Abroad (travel likely)RecruitingPHASE4

Fuzhou, China